Event MFM Meet the Industry: Pharma

1. SOME PHARMA FINANCIALS
PROF. DR. WOUTER DE MAESENEIRE

2. DISCLAIMER
 I am not a pharma/healthcare expert
 But I did quite some work for student in-
company projects or customized trainings for
 Pfizer, J&J (Janssen), Arseus, Capsugel, UCB,
Boehringher-Inghelheim,…
 IRC MFM last year: UCB
 I wrote a case on BigPharma vs Small Biotech
FSA
 I’ll give a broad overview of some of the issues

3. © Vlerick Business School3

4. © Vlerick Business School
PROFIT AND LOSS ACCOUNT/INCOME STATEMENT
4

5. © Vlerick Business School
APPLE: PROFIT AND LOSS ACCOUNT (P&L)
5

6. © Vlerick Business School
DO YOU KNOW…
6

7. © Vlerick Business School
AN UNFORESEEN OUTCOME…
7

8. © Vlerick Business School
LIPITOR
 Peak sales
 Cumulative sales (1996-2012)
8

9. © Vlerick Business School
PFIZER: PROFIT AND LOSS ACCOUNT (P&L)
9

12. 12

13. 13

14. 14

15. 15

16. 16

17. 17

18. 18

19. © Vlerick Business School
GALAPAGOS
19

20. © Vlerick Business School
GALAPAGOS: P&L
20

21. © Vlerick Business School21

22. © Vlerick Business School
GALAPAGOS: ASSETS
22

23. © Vlerick Business School
GALAPAGOS: EQUITY AND LIABILITIES
23

24. © Vlerick Business School
GALAPAGOS: CASH FLOW STATEMENT
24

25. © Vlerick Business School
A LOT OF BIG PHARMA & SMALL BIOTECH
DEALS
 M&A, alliances, milestone payments, co-
development, licencsing out,…
 Clear complementarities
25